Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00437762Phase 3Completed
A Phase 3 trial of botulinum toxin type A in Lateral Epicondylitis (LET), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00437762.